CAPTRUST Financial Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Sell
42,922
-1,643
-4% -$758K 0.03% 358
2026
Q1
$21.4M Sell
44,565
-792
-2% -$406K 0.04% 343
2025
Q4
$25.5M Buy
45,357
+782
+2% +$444K 0.05% 280
2025
Q3
$22.9M Buy
44,575
+4,003
+10% +$1.75M 0.05% 289
2025
Q2
$12.7M Buy
40,572
+34,199
+537% +$10.3M 0.03% 407
2025
Q1
$1.94M Buy
6,373
+674
+12% +$227K ﹤0.01% 923
2024
Q4
$1.89M Buy
5,699
+643
+13% +$218K 0.01% 911
2024
Q3
$1.69M Sell
5,056
-71
-1% -$27K 0.01% 923
2024
Q2
$2.11M Buy
5,127
+824
+19% +$326K 0.01% 798
2024
Q1
$1.74M Sell
4,303
-1,980
-32% -$696K 0.01% 862
2023
Q4
$1.93M Buy
6,283
+1,278
+26% +$345K 0.01% 926
2023
Q3
$1.21M Buy
5,005
+1,455
+41% +$372K ﹤0.01% 1095
2023
Q2
$853K Buy
3,550
+256
+8% +$53.2K ﹤0.01% 1304
2023
Q1
$619K Buy
3,294
+1,114
+51% +$230K ﹤0.01% 1289
2022
Q4
$463K Buy
2,180
+303
+16% +$60.5K ﹤0.01% 1381
2022
Q3
$295K Buy
1,877
+181
+11% +$28.9K ﹤0.01% 1554
2022
Q2
$254K Buy
1,696
+453
+36% +$65.6K ﹤0.01% 1525
2022
Q1
$203K Sell
1,243
-107
-8% -$17.6K ﹤0.01% 1713
2021
Q4
$294K Sell
1,350
-145
-10% -$30.4K ﹤0.01% 1401
2021
Q3
$283K Buy
1,495
+93
+7% +$17K ﹤0.01% 1332
2021
Q2
$248K Buy
1,402
+30
+2% +$5.18K ﹤0.01% 1374
2021
Q1
$225K Buy
1,372
+407
+42% +$62.3K ﹤0.01% 1391
2020
Q4
$134K Buy
965
+31
+3% +$3.91K ﹤0.01% 1374
2020
Q3
$107K Buy
934
+20
+2% +$2.31K ﹤0.01% 1316
2020
Q2
$85K Buy
+914
New +$77.8K ﹤0.01% 1403
2019
Q1
Sell
-75
Closed -$4K 1868
2018
Q4
$4K Buy
+75
New +$4.12K ﹤0.01% 1382

Other funds holding MEDP

CAPTRUST Financial Advisors's MEDP Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Medpace (MEDP) stake by 3.7% in Q2 2026, selling an estimated $758K and leaving 42,922 shares worth $22.7M. The position accounts for 0.03% of the portfolio, ranked #358.

CAPTRUST Financial Advisors first reported a position in MEDP in Q4 2018 and has held it in 26 quarters since. The position peaked at $25.5M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • CAPTRUST Financial Advisors held 42,922 shares of Medpace worth $22.7M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 1,643 Medpace shares in Q2 2026, an estimated $758K.
  • Medpace made up 0.03% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #358 holding.
  • CAPTRUST Financial Advisors first reported a position in Medpace in Q4 2018 and has held it in 26 quarters since.
  • CAPTRUST Financial Advisors's Medpace position peaked at $25.5M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.